MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-04-2026
Regeneron Pharmaceuticals Current Ratio 2011-2026 | REGN
Annual Current Ratio Regeneron Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.36 | 4.49 | 4.65 | 4.46 | 3.82 | 2.8 | 3.67 | 4.47 | 3.82 | 2.56 | 3.59 | 3.31 | 6.01 | 7.37 | 4.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.37 | 2.56 | 4.25 |
Quarterly Current Ratio Regeneron Pharmaceuticals
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.62 | 4.6 | 4.61 | 4.58 | 4.66 | 4.43 | 4.62 | 4.58 | 4.46 | 4.44 | - | 4.1 | 3.82 | 3.69 | 3.38 | 3.07 | 2.8 | 2.8 | 2.8 | 2.8 | 3.98 | 3.98 | 3.98 | 3.98 | 3.94 | 3.94 | 3.94 | 3.94 | 3.34 | 3.34 | 3.34 | 3.34 | 2.76 | 2.76 | 2.76 | 2.76 | 2.87 | 2.87 | 2.87 | 2.87 | 2.98 | 2.98 | 2.98 | 2.93 | 2.95 | 2.95 | 2.95 | 2.95 | 2.49 | 2.49 | 2.49 | 2.49 | 1.58 | 1.58 | 1.58 | 1.58 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.66 | 1.58 | 3.32 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
AbCellera Biologics
ABCL
|
3.48 | $ 3.58 | 0.42 % | $ 1.07 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | Canada |
 |
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | USA |
 |
AC Immune SA
ACIU
|
1.95 | $ 3.22 | 2.88 % | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
3.71 | $ 0.79 | - | $ 4.31 M | China |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
7.98 | - | 10.36 % | $ 9.8 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
ADC Therapeutics SA
ADCT
|
1.2 | $ 4.2 | -0.47 % | $ 105 M | Schweiz |
 |
argenx SE
ARGX
|
8.81 | $ 708.98 | 0.81 % | $ 25 B |  Niderland |
 |
Ascendis Pharma A/S
ASND
|
0.889 | $ 231.11 | 0.03 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.45 | -4.43 % | $ 8.3 B |  Australia |
 |
Atea Pharmaceuticals
AVIR
|
7.92 | $ 6.02 | -0.5 % | $ 491 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
4.74 | $ 6.59 | -0.6 % | $ 180 M |  Israel |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
BioCardia
BCDA
|
0.651 | $ 1.29 | 1.57 % | $ 27.3 M | USA |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
Athersys
ATHX
|
2.38 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | Canada |
 |
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | USA |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 14.36 | - | $ 210 M | USA |
 |
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | USA |
 |
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
1.77 | - | - | $ 521 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | Israel |
 |
BioNTech SE
BNTX
|
7.95 | $ 91.71 | 1.29 % | $ 27.2 B | Germany |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.64 | - | $ 16.6 M | USA |
 |
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | USA |
 |
Burford Capital Limited
BUR
|
2.14 | $ 8.17 | 1.49 % | $ 1.33 B | Britain |
 |
Autolus Therapeutics plc
AUTL
|
2.2 | $ 1.51 | -0.33 % | $ 385 M | Britain |
 |
Athira Pharma
ATHA
|
4.22 | - | - | $ 269 M | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.58 | -0.28 % | $ 7.79 B | Israel |